SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-14-010029
Filing Date
2014-02-14
Accepted
2014-02-14 06:44:33
Documents
2

Document Format Files

Seq Description Document Type Size
1 SC 13G/A a14-5059_2sc13ga.htm SC 13G/A 80074
2 EX-99.1 a14-5059_2ex99d1.htm EX-99.1 6139
  Complete submission text file 0001104659-14-010029.txt   87927
Mailing Address 2 LIBERTY SQUARE 9TH FLOOR BOSTON MA 02109
Business Address 2 LIBERTY SQUARE 9TH FLOOR BOSTON MA 02109 617 772-8500
Tekla Capital Management LLC (Filed by) CIK: 0001300336 (see all company filings)

IRS No.: 010628853 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SC 13G/A

Mailing Address 30 WORCESTER ROAD TORONTO A6 M9W 5X2
Business Address 30 WORCESTER ROAD TORONTO A6 M9W 5X2 416-798-3001
Intellipharmaceutics International Inc. (Subject) CIK: 0001474835 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1130
Type: SC 13G/A | Act: 34 | File No.: 005-85064 | Film No.: 14609465
SIC: 2834 Pharmaceutical Preparations